Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A3 | P47895 | 5/20 | 0.50 |
| ▸ | ALDH1A2 | O94788 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | DHODH | Q02127 | 1/20 | 0.40 |
| ▸ | HCRTR1 | O43613 | 6/20 | 0.39 |
| ▸ | HCRTR2 | O43614 | 6/20 | 0.39 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.38 |
| ▸ | SCD5 | Q86SK9 | 3/20 | 0.37 |
| ▸ | SCD | O00767 | 1/20 | 0.37 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14144746 | 0.90 | ALDH1A3 (0.47) | ALDH1A3ALDH1A2ALDH1A1HCRTR1HCRTR2 | |
| SCHEMBL342337 | 0.88 | ALDH1A3 (0.40) | ALDH1A3ALDH1A2ALDH1A1HCRTR1HCRTR2 | |
| SCHEMBL343089 | 0.88 | HCRTR1 (0.42) | ALDH1A3ALDH1A2ALDH1A1HCRTR1HCRTR2 | |
| SCHEMBL342552 | 0.87 | PREP (0.43) | ALDH1A3ALDH1A2ALDH1A1HCRTR1HCRTR2 | |
| SCHEMBL4563122 | 0.85 | SCD5 (0.42) | ALDH1A3ALDH1A2ALDH1A1HCRTR1HCRTR2 | |
| SCHEMBL341365 | 0.85 | AADAT (0.44) | ALDH1A3ALDH1A2ALDH1A1TSHR | |
| SCHEMBL4563773 | 0.84 | DRD2 (0.42) | HCRTR1HCRTR2TRPV1SCD5SCD | |
| SCHEMBL342015 | 0.81 | TRPV1 (0.38) | ALDH1A1HCRTR1HCRTR2TRPV1SCD5 | |
| SCHEMBL14144716 | 0.79 | GRM5 (0.40) | ALDH1A3HCRTR1HCRTR2 | |
| SCHEMBL14144748 | 0.79 | HCRTR1 (0.46) | ALDH1A3ALDH1A2ALDH1A1HCRTR1HCRTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120015974-A1 | IMIDAZOPYRIDINE INHIBITORS OF IAP | GENENTECH, INC. (US) | 2012-01-19 | — | — | US | disclosed |
| US-8063218-B2 | Imidazopyridine inhibitors of IAP | GENENTECH, INC. (US) | 2011-11-22 | — | — | US | disclosed |
| US-20100130539-A1 | IMIDAZOPYRIDINE INHIBITORS OF IAP | GENENTECH INC. (US) | 2010-05-27 | — | — | US | disclosed |
| EP-2125809-A1 | IMIDAZOPYRIDINE INHIBITORS OF IAP | Genentech, Inc. (US) | 2009-12-02 | — | — | EP | disclosed |
| WO-2008079735-A1 | IMIDAZOPYRIDINE INHIBITORS OF IAP | GENENTECH, INC. (US) | 2008-07-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120015974-A1 | IMIDAZOPYRIDINE INHIBITORS OF IAP | BIRC5, XIAP, BIRC3 | ALDH1A3 4275/4885ALDH1A2 4334/4885ALDH1A1 4176/4885 |
| US-20100130539-A1 | IMIDAZOPYRIDINE INHIBITORS OF IAP | BIRC5, XIAP, BIRC3 | ALDH1A3 4275/4885ALDH1A2 4334/4885ALDH1A1 4176/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.